Beo 7,90 USD nehmen
Anzeige
Meldung des Tages: „Echte Revolution“: Dieses MedTech-Unternehmen greift nach dem Milliardenmarkt
Neuester,
zuletzt geles. Beitrag
Antworten | Börsen-Forum Übersicht
Zurück
Weiter
... 89 90 91 93 94 95 ...
Antworten | Börsen-Forum Übersicht
Zurück
Weiter ... 89 90 91 93 94 95 ...
Ariad Pharma on the Top
Beiträge:
9.312
Zugriffe: 1.504.540 / Heute: 243
Zugriffe: 1.504.540 / Heute: 243
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +61,04%
Xtrackers Spain UCITS ETF 1D
Perf. 12M: +58,93%
Xtrackers Spain UCITS ETF 1C
Perf. 12M: +58,89%
Xtrackers ATX UCITS ETF 1C
Perf. 12M: +51,40%
Xtrackers Vietnam Swap UCITS ETF 1C
Perf. 12M: +49,01%
die einzige sierra auf die man(n) sich verlassen kann, ist jene:
twitter.com/lizadelsierra/media
twitter.com/lizadelsierra/media
dann würde es aber höher steigen ;-) denke da hat eine etwas größer investiert
heute sind ein paar Bios drann
Ariad / Peregrine und Rexahn, alle schön im plus
Ariad / Peregrine und Rexahn, alle schön im plus
t's true !! it's true !! ARIA being sold on wed next week
Rumors take a switch claiming ARIAD will be sold to Eli Lilly on Fed 4, 2014. CEO Interview rumors turn fact. Harvey Berger CEO management team exits after having created substantial and dramatic value for its shareholders.
The multibillion-dollar deal marks a coup for John Lechleiter, Eli Lilly's chairman, president and CEO who's executed the deal in an effort to broaden the big biotech's product lines as well as its pipeline.
The final price says a lot about president and CEO of Lilly. He scored big with a deal to buy ARAID for $276 million in cash and $445 million in milestones--after the $170 million milestone for an early approval gave way to a final $80 million payoff
Rumors take a switch claiming ARIAD will be sold to Eli Lilly on Fed 4, 2014. CEO Interview rumors turn fact. Harvey Berger CEO management team exits after having created substantial and dramatic value for its shareholders.
The multibillion-dollar deal marks a coup for John Lechleiter, Eli Lilly's chairman, president and CEO who's executed the deal in an effort to broaden the big biotech's product lines as well as its pipeline.
The final price says a lot about president and CEO of Lilly. He scored big with a deal to buy ARAID for $276 million in cash and $445 million in milestones--after the $170 million milestone for an early approval gave way to a final $80 million payoff
die hoffnung auch noch nicht aufgegeben 
finance.yahoo.com/mbview/threadview/...&tls=la%2Cd%2C3%2C3
sierraworldequityreview.blogspot.co.uk/2013/11/ready-…
Sorry, the page you were looking for in this blog does not exist.
Was die sagt ist noch nie eingetreten. Wie Stay schon erwähnte ist das alles nur laberei. Bei WMIH puscht die junge Lady auch immer.
Sierra says offer increased by Pfizer
Ready, Willing And Able_Pfizer (PFE) Increases Offer For Acquisition Of Ariad Pharmaceuticals (ARIA) Following Positive News On Iclusig From European Medicines Agency Ventures Sierra World Equity Review
HEADLINE: Ready, Willing And Able_Pfizer (PFE) Increases Offer For Acquisition Of Ariad Pharmaceuticals (ARIA) Following Positive News On Iclusig From European Medicines Agency Ventures Sierra World Equity Review.
Pfizer (PFE) Increases Offer For Acquisition Of Ariad Pharmaceuticals (ARIA)
Shares of Ariad Pharmaceuticals rose over 6% today on what Sierra's leads believe is an increased buyout offer placed on the table by big pharma Pfizer. Sierra and her team are monitoring any potential meeting activity at Pfizer HQ in New York City this weekend and will be providing instant updates as needed. Sierra will also be holding a live Skype conference call on Sunday afternoon with her team who are tracking the Pfizer-Ariad Pharmaceuticals potential buyout. For those interested in joining the Skype conference call the time and contact connection details will be published on Sierra's site Sunday afternoon.
Using complex algorithms in our price targets and ratings Sierra World Equity Review makes accurate calls! We now update our 10 day short term price targets and BUY or SELL ratings for each stock every 14 days. Sierra World Equity Review also provides results of a daily stringent Money Flow Index screen reflecting the most EXTREME overbought and oversold stocks across the markets, it is highly improbable these stocks can sustain their momentum thereby giving very high percentage BUY or SELL signals.
Sierra's MONEY FLOW INDEX Daily Screen of EXTREMELY Overbought & Oversold Stocks
Sierra World Equity Review is also smoking hot in our predictions!! From FDA Drug Approvals and Trials to Potential Joint Ventures, Mergers, Buyouts, Acquisitions and Lawsuit Settlements..... get THE Scoop, always on the cutting edge of BIG Breaking News. Sierra World Equity Review covers all sectors from Biotech to Oil stocks, Gold stocks, Penny stocks on the OTC as well as the S&P, Nasdaq, Dow Jones and Amex. Sierra World Equity Review made more correct calls in the last 17 months than all other Stock Reviews COMBINED!! We have had excellent success but please remember to always do your own due diligence in regards to any stocks we feature! Good luck in all your trades!
For the latest updates on these stocks and to learn more about Sierra go to: Sierra's Website and follow Sierra on Twitter
at 10:41 PM Posted by Sierra World Equity Review Less
Sentiment: Strong Buy
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem ARIAD Pharmaceuticals, Inc. Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 58 | ARIAD Pharmaceuticals Inc. | JoWu81 | Card60 | 25.04.21 01:33 | ||
3 | 46 | Ariad Pharmaceuticals Inc. A real hot stock! | FernandeZ | FernandeZ | 25.04.21 00:53 | |
| 18 | 4.875 | Ariad Pharmaceuticals - der letzte Thread | steven-bln | vstrecker | 25.04.21 00:38 | |
| 23 | 3.206 | Ariad Pharmaceuticals-Neu | Heron | Heron | 04.12.18 18:56 | |
| 36 | 9.311 | Ariad Pharma on the Top | MasterbrokerUSA | MasterbrokerUSA | 26.09.16 18:45 |